Marksans Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 to consider and approve unaudited financial results, standalone and consolidated, for the quarter and nine months ended December 31, 2024.
The above information is a part of company’s filings submitted to BSE.